Immune response elicited in the tumor microenvironment upon rMV‐SLAMblind cancer virotherapy

Oncolytic virotherapy is a promising therapy for cancer. We previously established a recombinant measles virus (rMV‐SLAMblind) that targets NECTIN4‐expressing cancer cells and demonstrated its antitumor effects using a xenograft model in an immunodeficient mouse. In the current study, to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Moritoh, Kanako, Shoji, Koichiro, Amagai, Yosuke, Fujiyuki, Tomoko, Sato, Hiroki, Yoneda, Misako, Kai, Chieko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154881/
https://www.ncbi.nlm.nih.gov/pubmed/36715555
http://dx.doi.org/10.1111/cas.15740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154881/
https://www.ncbi.nlm.nih.gov/pubmed/36715555
http://dx.doi.org/10.1111/cas.15740

Ejemplares similares